Tumor growth was substantially inhibited upon the short-term treatment with the BRAF and MEK inhibitor combination (On-tx group), and the tumors gradually progressed after 60 days of treatment (Resistance group), suggesting CR was successfully established in these cells (Fig. 2A, B). This evidence concerns the gene MAP2K7 and neoplasm.